
Standard BioTools Inc. (LAB) earnings
- Healthcare
- NASDAQ
- Market cap$225M
Next report
2027-03-03
In 104 daysQ4 FY2026Time not announced· Expected date
- EPS consensus
- -0.02
- -0.02 – -0.021 analyst
- Revenue consensus
- $21.0M
Latest result
16 days ago-$0.01EPS Miss
2026-11-03Q3 FY2026AMC
- EPS
- Reported / estimate-0.03 / -0.02
- Revenue
- $19.4M / $18.8M+3.1%
Stock reaction
+0.85%
-0.80 pts vs SPY
Session 2026-11-04
Recent quarters
Latest 3 quartersRevenue and stock reaction
Beat in 0 of 3 quarters with a measured stock reaction · beat then fell 0
| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-11-03 | -0.03 / -0.02 -$0.01* | $19.4M / $18.8M +3.1% | +0.85% -0.80 pts vs SPY Session 2026-11-04 |
Q2 FY2026 2026-08-05 | -0.07 / -0.01 -$0.06*¶ | $20.1M / $20.8M -3.4%¶ | +2.04% +2.20 pts vs SPY Session 2026-08-06 |
Q1 FY2026 2026-05-05 | -0.02 / -0.02 $0.00*¶ | $21.1M / $17.8M +18.8%¶ | -1.07% -2.46 pts vs SPY Session 2026-05-06 |
Reported / estimate
- Q3 FY2026 · 2026-11-03+0.85%EPS-0.03 / -0.02-$0.01*Revenue$19.4M / $18.8M+3.1%
- Q2 FY2026 · 2026-08-05+2.04%EPS-0.07 / -0.01-$0.06*¶Revenue$20.1M / $20.8M-3.4%¶
- Q1 FY2026 · 2026-05-05-1.07%EPS-0.02 / -0.02$0.00*¶Revenue$21.1M / $17.8M+18.8%¶
- *The estimate is under $0.10, so a percentage misleads; the gap is shown in dollars
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.